Anti-PEG antibodies associated with reduced therapeutic effect of patisiran in patients with hereditary transthyretin amyloidosis

Amyloid. 2024 Dec;31(4):342-343. doi: 10.1080/13506129.2024.2388713. Epub 2024 Aug 10.
No abstract available